NSPR — InspireMD, Inc.

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1433607 ·
Last close
$0.70
Market Cap
$32.83M
52W High
$1.82
52W Low
$0.69
ADV30
196,444
Next earnings
2026-05-04
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026
Dec 2025 3,149,000 1,180,000 -12,084,000 -11,761,000 69,404,000 8,939,000 14,203,000
Sep 2025 2,523,000 864,000 -13,051,000 -12,708,000 78,472,000 63,403,000 14,358,000
Jun 2025 1,778,000 313,000 -13,019,000 -13,151,000 33,342,000 11,509,000 13,099,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-35,103,000
Investing CF
$-30,560,000
Financing CF
$55,569,000
CapEx
$-1,662,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.73
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-302,292,000
Inventory
$3,396,000
Receivables
$2,568,000
ST Investments
$45,272,000
EBIT TTM
$-49,614,000
Pretax Income TTM
$-48,723,000
Interest Exp TTM
Analysts
3

Yahoo Snapshot (yfinance, live)

Total Revenue
$10,848,000
EBITDA
$-51,605,000
Free Cash Flow
$-21,118,500
Enterprise Value
$-5,626,887
Total Cash
$41,570,000
Total Debt
$3,109,000
Shares Out
46,838,962
Trailing EPS
$-0.70
Book Value
$0.93
ROE
-142.6%
ROA
-68.5%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 8,979,000 -49,614,000 -48,786,000 69,404,000 14,203,000 -35,103,000
Dec 2024 7,009,000 -33,503,000 -32,005,000 46,807,000 10,721,000 -21,868,000
Dec 2023 6,205,000 -21,143,000 -19,916,000 47,643,000 8,142,000 -16,376,000
Dec 2022 5,171,000 -18,713,000 -18,491,000 24,653,000 7,260,000 -15,542,000

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-0.61

Peers — same industry

TickerNameMarket CapLastDaily %
BDMD Baird Medical Investment Holdings Ltd $32.62M $1.02
PAVM PAVmed Inc. $33.50M $4.68
VASO VASO Corp $31.68M $0.18
RDGL VIVOS INC $31.61M $0.06
TELA TELA Bio, Inc. $35.18M $0.79

News headlines (Yahoo Finance, 1h cache)

InspireMD Posts Positive CGUARDIANS II Data for CGuard Prime TCAR
2026-06-16 16:41 · Yahoo
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-06-12 20:05 · Yahoo
InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures
2026-06-11 12:00 · Yahoo
InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures
2026-06-08 12:00 · Yahoo
InspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare Conference
2026-05-06 20:05 · Yahoo
InspireMD, Inc. Q1 2026 Earnings Call Summary
2026-05-05 12:30 · Yahoo
InspireMD, Inc. (NSPR) Reports Q1 Loss, Tops Revenue Estimates
2026-05-04 21:50 · Yahoo
InspireMD (NSPR) Q4 2025 Earnings Transcript
2026-05-04 21:28 · Yahoo
InspireMD (NSPR) Q2 2025 Earnings Transcript
2026-05-04 21:26 · Yahoo
InspireMD Reports First Quarter 2026 Financial Results
2026-05-04 20:05 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.